USPTO Examiner BACHMAN LINDSEY MICHELE - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18882654CERVICAL CONTROL SYSTEMS AND CERVICAL CONTROL DEVICESSeptember 2024March 2026Allow1830YesNo
18797435LOCK-CUT MECHANISM AND MEDICAL SUTURING DEVICEAugust 2024February 2026Allow1900NoNo
18666755ADJUSTABLE HEART VALVE IMPLANTMay 2024August 2025Allow1510YesNo
18643899EMBOLIC DEFLECTION DEVICEApril 2024March 2025Allow1100YesNo
18642626CARDIAC VALVE REPLACEMENTApril 2024October 2025Allow1820NoNo
18415106METHOD, DEVICE, AND NETWORK FOR STOPPING BLOOD LOSSJanuary 2024September 2025Abandon2020YesNo
18403108Catheter Systems For Accessing The Brain For Treatment Of Ischemic StrokeJanuary 2024January 2026Allow2410YesNo
18396573INFLATION DEVICES AND SYSTEMS FOR BALLOON CATHETERS AND METHODS FOR USEDecember 2023December 2025Abandon2320NoNo
18507576HEMOSTATIC DEVICENovember 2023March 2026Allow2810YesNo
18368352METHOD, DEVICE, AND NETWORK FOR STOPPING BLOOD LOSSSeptember 2023April 2024Allow720YesNo
18367980METHODS AND DEVICES FOR SECURING EPICARDIAL DEVICESSeptember 2023November 2024Allow1401NoNo
18359583CUTTING BALLOON CATHETER WITH CONCEALED BLADESJuly 2023May 2025Allow2200YesNo
18356432DEVICES AND METHODS FOR TARGETED DELIVERY OF A SUBSTANCEJuly 2023August 2025Allow2550YesYes
18131243Elastic Limb TourniquetApril 2023January 2026Abandon3310NoNo
18024795Cervical Support System and Method of UseMarch 2023December 2025Allow3321YesNo
18110798SURGICAL SYSTEMS AND DEVICES, INCLUDING METHODS FOR CONFIGURING SURGICAL SYSTEMS AND DEVICES, FOR MANAGING POSTPARTUM HEMORRHAGINGFebruary 2023May 2025Allow2700YesNo
18107925AUTOMATED EMERGENCY PNEUMATIC TOURNIQUETFebruary 2023August 2025Abandon3050YesNo
18102822PERFUSION BALLOON WITH INTERNAL VALVEJanuary 2023June 2025Allow2921YesNo
18090892DELIVERY SYSTEM AND METHOD FOR SELF-CENTERING A PROXIMAL END OF A STENT GRAFTDecember 2022February 2025Abandon2510NoNo
18080995STEERABLE CATHETERS AND RELATED METHODSDecember 2022September 2025Abandon3411NoNo
17991783BIOCYL PLAQUE EXTRACTORNovember 2022August 2024Allow2110YesNo
17921786MEDICAL LOOP AND MANUFACTURING METHOD THEREOFOctober 2022September 2025Abandon3501NoNo
17967633DEVICE FOR CARDIAC SURGERYOctober 2022October 2025Allow3620YesNo
17956154SOFT ANCHORS WITH SOFT EYELETSSeptember 2022February 2025Allow2810YesNo
17934301MEDICAL DEVICE WITH REMOVABLE MOTORSeptember 2022April 2025Allow3110YesNo
17946644DEVICES AND METHODS FOR TARGETED DELIVERY OF A SUBSTANCESeptember 2022July 2023Allow1031YesNo
17932014VENTRICULAR STRUCTURE RESHAPING ATRIO-VENTRICULAR VALVESeptember 2022May 2024Allow2000YesNo
17822687INTRAOCULAR LENS INSERTION SYSTEMAugust 2022July 2024Allow2310YesNo
17813402AIR TURBINE DRIVEN ROTARY VALVE FOR VITRECTOMY PROBEJuly 2022February 2025Allow3101NoNo
17866111DEVICES AND METHODS FOR TARGETED DELIVERY OF A SUBSTANCEJuly 2022April 2024Allow2151YesNo
17847445DEVICE FOR CARDIAC SURGERYJune 2022September 2024Allow2710NoNo
17826210BIOCYL PLAQUE EXTRACTORMay 2022July 2022Allow200YesNo
17664822EMBOLIC DEFLECTION DEVICEMay 2022January 2024Allow2000YesNo
17739585DEVICES AND METHODS FOR TARGETED DELIVERY OF A SUBSTANCEMay 2022August 2022Allow300NoNo
17724318COMPRESSION BALLOON WITH A RIGID FOOT FOR HEMOSTASISApril 2022September 2024Abandon2910NoNo
17766920Medical Device for Applying Force on Biological Tissue, or the LikeApril 2022July 2025Allow3911NoNo
17648411FLEXIBLE SURGICAL INSTRUMENT WITH STRUCTURAL BONES IN A CROSSED ARRANGEMENTJanuary 2022July 2024Allow3010YesNo
17577873CERUMEN REMOVAL APPARATUSJanuary 2022September 2024Abandon3220NoNo
17559242DIRECT PULL SURGICAL GRIPPERDecember 2021July 2024Allow3110NoNo
17621556LYMPHATIC ANASTOMOSIS DEVICES AND METHODSDecember 2021February 2026Allow5030YesNo
17543179SOFT EMBOLIC IMPLANTDecember 2021October 2024Abandon3411YesNo
17510911MAGNETICALLY DRIVEN ATHERECTOMY SYSTEMOctober 2021April 2024Allow2930YesNo
17507052SYSTEMS AND METHODS FOR PROTECTING THE CEREBRAL VASCULATUREOctober 2021April 2024Allow3020NoNo
17494309METHODS FOR SECURING A CARDIAC TISSUE ANCHOROctober 2021April 2025Allow4230YesNo
17481908Method and apparatus for oral hygieneSeptember 2021July 2025Abandon4640YesYes
17476022Phlebotomy Cuff AssemblySeptember 2021July 2024Abandon3420NoNo
17472478PERSONAL CLEANSING WANDSeptember 2021April 2023Allow1930YesNo
17412352Cardiac Valve ReplacementAugust 2021December 2023Allow2810YesNo
17385463STENT GRAFT DELIVERY DEVICEJuly 2021June 2023Allow2300YesNo
17368551DEVICES AND METHODS FOR TARGETED DELIVERY OF MATERIALJuly 2021March 2024Abandon3201NoNo
17350893CANNULATION DEVICES, SYSTEMS, AND METHODSJune 2021March 2025Allow4510NoNo
17349152FRAME FOR PROSTHETIC VALVEJune 2021May 2023Allow2300YesNo
17326789Suture SystemMay 2021August 2024Allow3920YesNo
17303088INTRAGASTRIC DEVICEMay 2021January 2026Abandon5640NoNo
17242975INCISION-LESS FACE LIFT WITH STEERABLE NEEDLEApril 2021September 2023Allow2820YesNo
17232421Medical Device Delivery System and Methods of Delivering Medical DevicesApril 2021February 2024Allow3420YesNo
17269111DEVICE COMPRISING MICRONEEDLES FOR SKIN-COLORINGFebruary 2021November 2024Abandon4510NoNo
17167486ULTRASONIC SURGICAL BLADEFebruary 2021July 2023Allow2910YesNo
17120116CERVICAL CERCLAGE APPLICATOR AND METHODDecember 2020December 2022Abandon2410NoNo
17115916ADJUSTABLE STIFFENER FOR SURGICAL INSTRUMENTSDecember 2020January 2024Allow3821YesNo
17116790THERAPEUTIC TREATMENT DEVICE WITH INVERTED BRAIDED VESSEL OCCLUDERDecember 2020July 2025Allow5530NoNo
17056040DEVICE FOR DENUDING A BODY LUMENNovember 2020July 2024Abandon4320NoNo
16949829METHODS OF MANAGING NEUROVASCULAR OBSTRUCTIONSNovember 2020June 2023Allow3110YesNo
17054319HEMOSTASIS AID AND TOURNIQUETNovember 2020September 2025Abandon5941NoNo
17080639DELIVERY ASSISTANCE TOOL FOR SHOULDER DYSTOCIAOctober 2020September 2023Abandon3510NoNo
17077205EYE-RELATED INTRABODY PRESSURE IDENTIFICATION AND MODIFICATIONOctober 2020May 2024Abandon4310NoNo
17076667DELIVERY ASSISTANCE DEVICE FOR VAGINAL BREECH DELIVERYOctober 2020January 2023Abandon2710NoNo
17047494CATHETER FOR ACTIVE SLICING/SCORING AND RELATED METHODSOctober 2020November 2023Allow3721NoNo
17064468TISSUE EXPANDERS AND METHODS OF USEOctober 2020November 2025Abandon6030NoYes
17030207HEMOSTATIC DEVICESeptember 2020June 2024Allow4530NoNo
17021601Scaffolds for Joining Layers of Tissue at Discrete PointsSeptember 2020August 2023Allow3410YesNo
17016948ADJUSTABLE UTERINE COMPRESSION APPARATUS FOR POSTPARTUM HEMORRHAGESeptember 2020January 2021Allow500YesNo
16937488PERSONALIZED TOURNIQUET CUFF ASSEMBLYJuly 2020March 2023Abandon3240YesNo
16910048METHOD TO STOP BLEEDING, WITH SHORT HEMOSTASIS DURATION USING A LOW DOSE OF ANTICOAGULANTJune 2020August 2023Abandon3811NoNo
16901965METHODS AND DEVICES FOR GASTRICINTESTINAL TRACT BYPASSJune 2020August 2024Allow5030YesNo
16893692APPARATUS FOR BREAKING THROMBUS AND ASPIRATING THROMBUSJune 2020October 2023Abandon4020NoNo
16765119CONNECTING AND RELEASING STRUCTURE FOR BALLOON SYSTEMMay 2020November 2023Allow4221YesNo
16877457Proximal Tab for Side-Delivered Transcatheter Heart Valve ProsthesisMay 2020February 2022Abandon2100NoNo
16764798FOREIGN BODY EXTRACTION DEVICEMay 2020September 2025Abandon6090YesNo
16871023POSITIONING UNIT WITH A PLURALITY OF INDICATORS FOR GUIDING A NEEDLEMay 2020December 2021Allow1921YesNo
16869278DELIVERY SYSTEM AND METHOD FOR SELF-CENTERING A PROXIMAL END OF A STENT GRAFTMay 2020September 2022Allow2910NoNo
16866795MEDICAL GRIPPING TOOLMay 2020September 2022Abandon2920YesNo
16846173Magnetic Anastomosis Device with Opposing Coil DirectionalityApril 2020February 2024Abandon4630YesNo
16840112BONE ANCHOR HAVING DEFORMABLE MEMBERSApril 2020January 2025Abandon5860NoNo
16647062METHODS AND DEVICES FOR SECURING EPICARDIAL DEVICESMarch 2020June 2023Allow3921YesNo
16816235TISSUE COMPRESSION DEVICEMarch 2020November 2023Abandon4421NoNo
16814814SUTURELESS DEVICE AND METHOD FOR CLOSING A TISSUE OPENINGMarch 2020November 2022Allow3210YesNo
16807613VASCULAR FILTER SYSTEMMarch 2020January 2023Allow3520YesNo
16640781DELIVERY SYSTEM AND METHOD OF ASSEMBLING SUCHFebruary 2020August 2022Allow3011YesNo
16794813HEMOSTASIS DEVICE WITH CUSTOMIZABLE STRAPSFebruary 2020September 2023Abandon4320NoNo
16795082Adjustable Heart Valve ImplantFebruary 2020August 2020Allow610YesNo
16785534FAST-ACTING TOURNIQUET DEVICE AND METHODS FOR USING SAMEFebruary 2020December 2025Abandon6040YesYes
16780542Dynamic Reconfigurable Microvalve Protection DeviceFebruary 2020July 2022Abandon2910NoNo
16779037LONG HOOD RETRIEVAL DEVICEJanuary 2020November 2023Abandon4630NoNo
16738125SYSTEM, METHOD, AND APPARATUS FOR CONFIGURATION, DESIGN, AND OPERATION OF AN ACTIVE CANNULA ROBOTJanuary 2020December 2024Abandon5940NoNo
16737073SOFT ANCHORS WITH SOFT EYELETSJanuary 2020March 2023Abandon3820NoNo
16737066INSERTER ASSEMBLY WITH SUTURE PROTECTOR TUBING AND METHOD OF USEJanuary 2020November 2024Allow5840YesNo
16736529ROBOTIC SURGICAL SYSTEMJanuary 2020October 2022Allow3300NoNo
16724897Balloon CatheterDecember 2019October 2022Abandon3330NoNo
16724261DIRECT PULL SURGICAL GRIPPERDecember 2019September 2021Allow2100NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BACHMAN, LINDSEY MICHELE.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
24
Examiner Affirmed
16
(66.7%)
Examiner Reversed
8
(33.3%)
Reversal Percentile
55.3%
Higher than average

What This Means

With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
43
Allowed After Appeal Filing
11
(25.6%)
Not Allowed After Appeal Filing
32
(74.4%)
Filing Benefit Percentile
37.1%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BACHMAN, LINDSEY MICHELE - Prosecution Strategy Guide

Executive Summary

Examiner BACHMAN, LINDSEY MICHELE works in Art Unit 3771 and has examined 239 patent applications in our dataset. With an allowance rate of 59.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.

Allowance Patterns

Examiner BACHMAN, LINDSEY MICHELE's allowance rate of 59.0% places them in the 19% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BACHMAN, LINDSEY MICHELE receive 3.17 office actions before reaching final disposition. This places the examiner in the 90% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BACHMAN, LINDSEY MICHELE is 43 months. This places the examiner in the 17% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +40.7% benefit to allowance rate for applications examined by BACHMAN, LINDSEY MICHELE. This interview benefit is in the 88% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.3% of applications are subsequently allowed. This success rate is in the 11% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 12.5% of cases where such amendments are filed. This entry rate is in the 13% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 35.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 34% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 21% percentile among all examiners. Of these withdrawals, 37.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 52.4% are granted (fully or in part). This grant rate is in the 52% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.7% of allowed cases (in the 73% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.4% of allowed cases (in the 64% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.